The United States is set to cease all health funding programs in Zimbabwe by the end of September, following Zimbabwe’s decision to decline a new bilateral health Memorandum of Understanding (MOU). US Ambassador Pamela Tremont announced the move, emphasizing that America respects Zimbabwe’s sovereign decision.
For over two decades, the United States has been a pivotal partner in Zimbabwe’s health sector, particularly in the fight against HIV. This support included providing anti-retroviral drugs (ARVs), pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), allowances for health workers, and various family planning methods. These programs were instrumental in Zimbabwe achieving over 95% HIV epidemic control, with 97% of people living with HIV knowing their status, 98% receiving antiretroviral therapy, and 96% achieving suppressed viral loads.
Ambassador Tremont stated that the U.S.-Zimbabwe relationship is now pivoting from one focused largely on health and humanitarian assistance to one built on broader economic, trade, and investment opportunities. The Zimbabwean government had publicly misrepresented that the United States sought health data and key minerals in exchange for the funding, a claim that led to the rejection of the new funding model.
Key Players Involved
- Ambassador Pamela Tremont: US Ambassador to Zimbabwe, who announced the cessation of health funding.
- Zimbabwean Government: Declined the new US health funding MOU.
- Ministry of Health and Child Care (Zimbabwe): Working with the US Embassy and partners for a responsible handover of programs.
Event Timeline
- September 23, 2026: US Ambassador Pamela Tremont announces the impending end of US health funding.
- End of September 2026: US-supported health programs in Zimbabwe are scheduled to conclude.
